University City-based Vitara Biomedical is currently working on an artificial womb for premature babies and is getting closer to human clinical trials, writes Liz…

After spending years advocating against the FDA-enacted restrictions that critics believe to be discriminatory against gay and bisexual men, Adam Joseph donated blood for…

A West Chester pharmaceutical company finally achieved federal approval of a new drug candidate that treats a contagious skin disease, writes John George for the…

During his 40 years at the Pennsylvania College of Optometry at Salus University in Elkins Park, Mitchell Scheiman, OD, PhD ‘16, FAAO, has worked for…

Braeburn, which is based in Plymouth Meeting, has received Food and Drug Administration marketing clearance for its opioid use disorder drug Brixadi four years after…

A QMED article cites data from ECRI, the Plymouth Meeting healthcare safety nonprofit, warning about a pervasive medical risk. QMED’s publication, MD+DI, had…

Conshohocken-based Madrigal Pharmaceuticals saw its shares leap in value after the company reported additional positive late-stage clinical trial data for its experimental non…

Collegeville resident Prem Ganesh, a senior bioengineering student at Temple, is back in on campus now. But he’s brought a summer’s worth of…

Philanthropists Susan and Steve Kelly, longtime supporters of the Children’s Hospital of Philadelphia (CHOP), are helping establish the Susan S. and Stephen P. Kelly…

The new analytical testing services laboratory opened by the Center for Breakthrough Medicines at the Discovery Labs complex in King of Prussia aims to address…

The CEO of a Radnor-based pharmaceutical company, Dr. Scott Braunstein, M.D., has made a top 25 list of Biotech CEOs for 2022, compiled…

The experimental COVID-19 pill developed by Merck, the pharmaceutical giant with sizable operations in West Point, and its partner Ridgeback Biotherapeutics, is less effective…

A new study by the Centers for Disease Control and Prevention (CDC) found the Pfizer COVID-19 vaccine to be 93 percent effective in protecting…

A COVID-19 pill created by Merck, the pharmaceutical giant with sizable operations in West Point, and Ridgeback Biotherapeutics performed well in a key study…

Several local universities are starting to enact vaccination policies for students and staff, before they can be on campus in the fall, writes Pete Bannan…

Merck, the pharmaceutical giant with sizable operations in West Point, has received another approval for its blockbuster cancer antibody Keytruda, writes Mark Terry for BioSpace…

Plymouth Meeting-based Inovio Pharmaceuticals saw its stock drop by 25 percent last week. This was after the U.S. government decided to pull its…

Merck, the pharmaceutical giant with sizable operations in West Point, has decided to discontinue the development of the experimental COVID-19 drug it acquired from…